Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2014-11-28 Major Shareholding Noti…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder ('Eccenovo AB (publ)') in the issuer ('Vitrolife AB'). It explicitly mentions 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage (4.6%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2014-11-28 English
Vitrolifes aktiekapital och antal aktier per den 28 november 2014
Share Issue/Capital Change Classification · 98% confidence The document is a 'Pressmeddelande' (Press Release) dated November 28, 2014, detailing the total number of outstanding shares, the number of shares held in treasury, and the resulting share capital as of that date. It explicitly mentions an increase in shares due to a 'apportemission' (share issue in exchange for assets) related to an acquisition. This content directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a general regulatory filing (RNS) because it is highly specific to capital structure, nor is it a dividend notice (DIV) or a transaction in own shares (POS), as it details the result of a new issuance.
2014-11-28 Swedish
Vitrolife’s share capital and number of shares on November 28, 2014
Share Issue/Capital Change Classification · 98% confidence The document is a press release dated November 28, 2014, detailing a change in the total number of shares and the share capital of Vitrolife AB. It explicitly states the increase in shares (1,879,179) is due to a non-cash issue related to an acquisition. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition of 'Share Issue/Capital Change' (Code: SHA). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific capital event.
2014-11-28 English
Vitrolife AB (publ) completes the acquisition of Unisense FertiliTech A/S and has therefore resolved to carry out a non-cash issue
Capital/Financing Update Classification · 98% confidence The document is a press release dated November 26, 2014, announcing that Vitrolife AB has completed the acquisition of Unisense FertiliTech A/S by issuing new shares (a non-cash issue). This action directly relates to a change in the company's capital structure and financing activities (issuing shares as consideration for an acquisition). This fits the definition of 'Capital/Financing Update' (CAP). While it involves shares, it is not a general share issue announcement (SHA) but specifically tied to a financing/acquisition event. It is not a full 10-K, IR, or ER, nor is it a simple announcement of a report (RPA).
2014-11-26 English
Vitrolife AB (publ) fullbordar förvärvet av Unisense FertiliTech A/S samt beslutar med anledning därav om apportemission
Share Issue/Capital Change Classification · 99% confidence The document is titled "Pressmeddelande" (Press Release) and details a specific corporate action: the completion of an acquisition (Unisense FertiliTech A/S) financed through a share issue (apportemission/share swap). This action directly relates to changes in the company's capital structure and financing activities. The key terms are 'förvärvet' (acquisition), 'apportemission' (share issue in kind), and 'aktiekapital' (share capital increase). This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific, material financing event.
2014-11-26 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a 'delårsrapport' (interim report) for Vitrolife AB covering the period of January to September 2014. It contains detailed financial statements, key performance indicators (KPIs), management commentary, and analysis of business segments. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2014
2014-11-06 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.